Status:
COMPLETED
Evaluation of Quality of Care - Multi-disciplinary Risk Assessment and Management Programme for Patients With Hypertension, HA (QoC RAMP-HT)
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Hospital Authority, Hong Kong
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Hypertension (HT) is one of the major cause of morbidity and among the top 10 causes of deaths in Hong Kong in 2008 (Department of Health 2009). The Hospital Authority (HA) has initiated service impro...
Eligibility Criteria
Inclusion
- HT
- aged \<80
- Suboptimal BP control (average systolic blood pressure (SBP) ≥ 140mmHg or average diastolic blood pressure (DBP) ≥ 90mmHg)
Exclusion
- Patients will be excluded if they are unable to understand or communicate in Chinese language, or refuse to give consent.
- Patients will be excluded if they had prior history of diabetes and existing cardiovascular diseases
Key Trial Info
Start Date :
September 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
2496 Patients enrolled
Trial Details
Trial ID
NCT02219958
Start Date
September 1 2012
End Date
April 1 2017
Last Update
September 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong Island, Hong Kong